Trade groups for meat producers have questioned the link to cardiovascular disease, saying studies that ask people to recall what they ate over long periods are imprecise.
Sleep disorders, such as sleep apnea, are associated with higher risk of cardiovascular disease, but few studies have examined sleep abnormalities and stroke, researchers said.
Most big studies confirming the cardiovascular benefits of omega-3s have tested either docosahexaenoic acid (DHA), an omega-3 found in salmon, sardines and breast milk, or another fish oil called eicosapentaenoic acid (EPA).
Certainly, such cancer studies can turn up cardiovascular risk.
Trade groups for meat producers have questioned the link between red meat and cardiovascular disease on the grounds that studies that ask people to recall what they ate over long periods are imprecise.
They found that, as with other studies, patients with cardiovascular disease who were obese or overweight were less likely to die over the next seven years than people of a normal weight who had the condition.
In fact, Arena last week withdrew its application to market Belvia in Europe after the European Medicines Agency pointed to potential cardiovascular risks and tumors found in animal studies.
FORBES: Will The Prescription Diet Pill Market Finally Bulk Up?
Other studies have linked adversity in childhood with cardiovascular disease in adults.
Despite several studies showing an association with alcohol intake and reduced cardiovascular risk, guidance from the American Heart Association warns people not to start drinking if they do not already drink alcohol.
Many studies have linked consumption of red and processed meat to cardiovascular disease and some cancers.
Many studies over the years have linked consumption of red and processed meat to cardiovascular disease and some cancers.
Other studies have focused on specific conditions affecting the most Americans, things such as cardiovascular disease, obesity, type 2 diabetes and depression.
An analysis of 10 studies involving a total of 393 patients, published earlier this year in the Journal of Thoracic and Cardiovascular Surgery, found between 26% and 83% of patients getting the new surgery were able to stop taking proton-pump inhibitors.
The investigators of those studies determined at the time that the differences were not meaningful and did not establish an increased or decrease cardiovascular risk for Celebrex.
应用推荐